These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19190117)

  • 1. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells.
    Morales C; García MJ; Ribas M; Miró R; Muñoz M; Caldas C; Peinado MA
    Mol Cancer Ther; 2009 Feb; 8(2):424-32. PubMed ID: 19190117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel role for non-homologous end joining in the formation of double minutes in methotrexate-resistant colon cancer cells.
    Meng X; Qi X; Guo H; Cai M; Li C; Zhu J; Chen F; Guo H; Li J; Zhao Y; Liu P; Jia X; Yu J; Zhang C; Sun W; Yu Y; Jin Y; Bai J; Wang M; Rosales J; Lee KY; Fu S
    J Med Genet; 2015 Feb; 52(2):135-44. PubMed ID: 25537274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the propensity for gene amplification between near-tetraploid and near-diploid V79 clones resistant to 150 nM methotrexate.
    Hashimoto MW; Nikaido O; Kobayashi N; Chang CC; Trosko JE; Mori T
    Carcinogenesis; 1996 Mar; 17(3):389-94. PubMed ID: 8631121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines.
    Hattinger CM; Stoico G; Michelacci F; Pasello M; Scionti I; Remondini D; Castellani GC; Fanelli M; Scotlandi K; Picci P; Serra M
    Genes Chromosomes Cancer; 2009 Apr; 48(4):289-309. PubMed ID: 19105235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic determinants of methotrexate responsiveness and resistance in colon cancer cells.
    Morales C; Ribas M; Aiza G; Peinado MA
    Oncogene; 2005 Oct; 24(45):6842-7. PubMed ID: 16007155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
    Kündig C; Leblanc E; Papadopoulou B; Ouellette M
    Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of the human dihydrofolate reductase gene via double minutes is initiated by chromosome breaks.
    Singer MJ; Mesner LD; Friedman CL; Trask BJ; Hamlin JL
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7921-6. PubMed ID: 10859355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with decreased binding to methotrexate in a human colon carcinoma cell line, HCT-8R4, resistant to this drug.
    Srimatkandada S; Schweitzer BI; Moroson BA; Dube S; Bertino JR
    J Biol Chem; 1989 Feb; 264(6):3524-8. PubMed ID: 2914962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective overproduction of human dihydrofolate reductase in a methotrexate-resistant human-mouse somatic cell hybrid.
    Sastry KJ; Chan TS; Rodriguez LV
    Biochem Biophys Res Commun; 1985 Oct; 132(2):795-803. PubMed ID: 4062946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].
    Sakai K
    Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray induction of methotrexate resistance due to dhfr gene amplification.
    Hahn P; Nevaldine B; Morgan WF
    Somat Cell Mol Genet; 1990 Sep; 16(5):413-23. PubMed ID: 2122527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides.
    Morganti M; Coronnello M; Caciagli B; Biondi C; Quattrone A; Capaccioli S; Mazzei T; Mini E
    Anticancer Drugs; 2000 Apr; 11(4):285-94. PubMed ID: 10898545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
    Serra M; Reverter-Branchat G; Maurici D; Benini S; Shen JN; Chano T; Hattinger CM; Manara MC; Pasello M; Scotlandi K; Picci P
    Ann Oncol; 2004 Jan; 15(1):151-60. PubMed ID: 14679136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of resistance to antifolates, a review.
    Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
    Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting homologous recombination decreases extrachromosomal amplification but has no effect on intrachromosomal amplification in methotrexate-resistant colon cancer cells.
    Cai M; Zhang H; Hou L; Gao W; Song Y; Cui X; Li C; Guan R; Ma J; Wang X; Han Y; Lv Y; Chen F; Wang P; Meng X; Fu S
    Int J Cancer; 2019 Mar; 144(5):1037-1048. PubMed ID: 30070702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells.
    Affleck JG; Nowickyj SM; Walker VK
    Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase.
    Bürkle A; Heilbronn R; zur Hausen H
    Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective killing of methotrexate-resistant cells carrying amplified dihydrofolate reductase genes.
    Urlaub G; Landzberg M; Chasin LA
    Cancer Res; 1981 May; 41(5):1594-601. PubMed ID: 7194140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new myeloblastic leukemia cell line with double minute chromosomes. Induction of methotrexate resistance and dihydrofolate reductase gene amplification.
    Saito H; Kishi K; Narita M; Furukawa T; Nagura E; Maekawa T; Abe T; Shibata A
    Leuk Res; 1992; 16(3):217-26. PubMed ID: 1560671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression.
    Aoki Y; Kubota Y; Masaki N; Obara K; Tome Y; Bouvet M; Nishida K; Hoffman RM
    Anticancer Res; 2024 Jul; 44(7):2787-2792. PubMed ID: 38925854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.